Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML)

Fig. 1

CD7 expression in healthy donors and R/R AML patients A CD7 expression in normal immune cells of peripheral blood from healthy donors and AML patients. B–E Histogram of CD7 expression analysis in T cells, B cells, monocytes, and neutrophils from R/R AML patients and healthy donors (HDs) (n = 3). F FCM was used to determine the percentage of CD7 expression in AML patients with microscopic residual disease (MRD). G Images of CD7 expression based on immunohistochemistry of bone marrow biopsies from R/R AML patients. ns, not significant

Back to article page